CA2531833A1 - Poly-4-hydroxybutyrate matrices for sustained drug delivery - Google Patents

Poly-4-hydroxybutyrate matrices for sustained drug delivery Download PDF

Info

Publication number
CA2531833A1
CA2531833A1 CA002531833A CA2531833A CA2531833A1 CA 2531833 A1 CA2531833 A1 CA 2531833A1 CA 002531833 A CA002531833 A CA 002531833A CA 2531833 A CA2531833 A CA 2531833A CA 2531833 A1 CA2531833 A1 CA 2531833A1
Authority
CA
Canada
Prior art keywords
hydroxybutyrate
poly
drug delivery
systems
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002531833A
Other languages
French (fr)
Other versions
CA2531833C (en
Inventor
Vasif N. Hasirci
Dilek Keskin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tepha Inc
Original Assignee
Tepha, Inc.
Vasif N. Hasirci
Dilek Keskin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tepha, Inc., Vasif N. Hasirci, Dilek Keskin filed Critical Tepha, Inc.
Publication of CA2531833A1 publication Critical patent/CA2531833A1/en
Application granted granted Critical
Publication of CA2531833C publication Critical patent/CA2531833C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

Biodegradable controlled release systems providing prolonged controlled release of drugs, and methods for the manufacture thereof are disclosed. The systems are formed from a biocompatible, biodegradable polymer, in particular poly-4-hydroxybutyrate (PHA4400) or copolymers thereof. Copolymers of 4-hydroxybutyrate include but are not limited to poly-3-hydroxybutyrate-co-4-hydroxybutyrate (PHA3444), and poly-4-hydoxybutyrate-co-glycolate (PHA4422).
Drugs are generally incorporated into the polymer using a method that yields a uniform dispersion. The type of drug and the quantity are selected based on the known pharmaceutical properties of these compounds. The systems may be administered for example by implantation, injection, topical administration, or oral ingestion. They may also be used in combination with a medical device, for example, a stent. A major advantage of the drug delivery system is that it does not need to be removed after use since it is slowly degraded and cleared by the patient's body. The device has desirable physical properties, including strength, modulus and elongation.
CA002531833A 2003-07-08 2004-07-08 Poly-4-hydroxybutyrate matrices for sustained drug delivery Active CA2531833C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US48537303P 2003-07-08 2003-07-08
US60/485,373 2003-07-08
US49143003P 2003-07-30 2003-07-30
US60/491,430 2003-07-30
PCT/US2004/022040 WO2005007195A1 (en) 2003-07-08 2004-07-08 Poly-4-hydroxybutyrate matrices for sustained drug delivery

Publications (2)

Publication Number Publication Date
CA2531833A1 true CA2531833A1 (en) 2005-01-27
CA2531833C CA2531833C (en) 2009-10-20

Family

ID=34083339

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002531833A Active CA2531833C (en) 2003-07-08 2004-07-08 Poly-4-hydroxybutyrate matrices for sustained drug delivery

Country Status (7)

Country Link
US (1) US20050025809A1 (en)
EP (1) EP1651273B1 (en)
JP (1) JP2007528853A (en)
AU (1) AU2004257701B2 (en)
CA (1) CA2531833C (en)
ES (1) ES2395077T3 (en)
WO (1) WO2005007195A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7318833B2 (en) * 2001-12-19 2008-01-15 Nmt Medical, Inc. PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
EP1467661A4 (en) * 2001-12-19 2008-11-05 Nmt Medical Inc Septal occluder and associated methods
US7220265B2 (en) * 2002-01-14 2007-05-22 Nmt Medical, Inc. Patent foramen ovale (PFO) closure method and device
WO2003082076A2 (en) * 2002-03-25 2003-10-09 Nmt Medical, Inc. Patent foramen ovale (pfo) closure clips
JP2005528181A (en) 2002-06-05 2005-09-22 エヌエムティー メディカル インコーポレイテッド Patent foramen ovale (PFO) occlusion device with radial and circumferential supports
WO2004037333A1 (en) 2002-10-25 2004-05-06 Nmt Medical, Inc. Expandable sheath tubing
CA2503349A1 (en) * 2002-11-06 2004-05-27 Nmt Medical, Inc. Medical devices utilizing modified shape memory alloy
CA2503666A1 (en) * 2002-12-09 2004-06-24 Nmt Medical, Inc. Septal closure devices
EP1651116B1 (en) * 2003-07-14 2013-06-26 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (pfo) closure device with catch system
US9861346B2 (en) * 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
WO2005018728A2 (en) * 2003-08-19 2005-03-03 Nmt Medical, Inc. Expandable sheath tubing
US20050273119A1 (en) 2003-12-09 2005-12-08 Nmt Medical, Inc. Double spiral patent foramen ovale closure clamp
US7871419B2 (en) * 2004-03-03 2011-01-18 Nmt Medical, Inc. Delivery/recovery system for septal occluder
US20050267524A1 (en) * 2004-04-09 2005-12-01 Nmt Medical, Inc. Split ends closure device
US8361110B2 (en) * 2004-04-26 2013-01-29 W.L. Gore & Associates, Inc. Heart-shaped PFO closure device
US8308760B2 (en) * 2004-05-06 2012-11-13 W.L. Gore & Associates, Inc. Delivery systems and methods for PFO closure device with two anchors
US7842053B2 (en) * 2004-05-06 2010-11-30 Nmt Medical, Inc. Double coil occluder
US8257389B2 (en) 2004-05-07 2012-09-04 W.L. Gore & Associates, Inc. Catching mechanisms for tubular septal occluder
EP1827247B8 (en) * 2004-09-24 2020-05-06 W.L. Gore & Associates, Inc. Occluder device double securement system for delivery/recovery of such occluder device
US8277480B2 (en) 2005-03-18 2012-10-02 W.L. Gore & Associates, Inc. Catch member for PFO occluder
EP1962695A1 (en) * 2005-12-22 2008-09-03 NMT Medical, Inc. Catch members for occluder devices
US8551135B2 (en) 2006-03-31 2013-10-08 W.L. Gore & Associates, Inc. Screw catch mechanism for PFO occluder and method of use
CA2647505C (en) * 2006-03-31 2014-07-29 Nmt Medical, Inc. Deformable flap catch mechanism for occluder device
US8870913B2 (en) 2006-03-31 2014-10-28 W.L. Gore & Associates, Inc. Catch system with locking cap for patent foramen ovale (PFO) occluder
US20080082083A1 (en) * 2006-09-28 2008-04-03 Forde Sean T Perforated expandable implant recovery sheath
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
WO2008124603A1 (en) 2007-04-05 2008-10-16 Nmt Medical, Inc. Septal closure device with centering mechanism
US7897168B2 (en) * 2007-04-13 2011-03-01 Medtronic Vascular, Inc. Degradable polymers incorporating gamma-butyrolactone
US9138562B2 (en) 2007-04-18 2015-09-22 W.L. Gore & Associates, Inc. Flexible catheter system
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
WO2009158724A2 (en) * 2008-06-27 2009-12-30 Tepha, Inc. Improved injectable delivery of microparticles and compositions therefore
US9492375B2 (en) * 2008-07-23 2016-11-15 Warsaw Orthopedic, Inc. Foam carrier for bone grafting
US20100226959A1 (en) * 2009-03-04 2010-09-09 Warsaw Orthopedic, Inc. Matrix that prolongs growth factor release
GB2470378A (en) * 2009-05-20 2010-11-24 Univ Westminster A controlled release composition for intraocular delivery of a therapeutic agent
US8956389B2 (en) 2009-06-22 2015-02-17 W. L. Gore & Associates, Inc. Sealing device and delivery system
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
US8758791B2 (en) 2010-01-26 2014-06-24 Warsaw Orthopedic, Inc. Highly compression resistant matrix with porous skeleton
US8475824B2 (en) 2010-01-26 2013-07-02 Warsaw Orthopedic, Inc. Resorbable matrix having elongated particles
US8734488B2 (en) 2010-08-09 2014-05-27 Ellipse Technologies, Inc. Maintenance feature in magnetic implant
US9162010B2 (en) 2010-11-09 2015-10-20 Tepha, Inc. Drug eluting cochlear implants
US9717779B2 (en) 2011-01-31 2017-08-01 Warsaw Orthopedic, Inc. Implantable matrix having optimum ligand concentrations
KR101599119B1 (en) * 2011-06-28 2016-03-02 닛뽕소다 가부시키가이샤 Calcium hypochlorite composition
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
ES2822000T3 (en) 2012-05-21 2021-04-28 Tepha Inc Resorbable bioceramics compositions of poly-4-hydroxybutyrate and copolymers
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
US9302029B2 (en) * 2013-10-31 2016-04-05 Tepha, Inc. Pultrusion of poly-4-hydroxybutyrate and copolymers thereof
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
WO2016048950A1 (en) 2014-09-22 2016-03-31 Tepha, Inc. Oriented p4hb implants containing antimicrobial agents
EP3676330A1 (en) 2017-08-31 2020-07-08 University of Westminster Nerve conduits
EP3720514B1 (en) 2017-12-04 2022-04-13 Tepha, Inc. Vacuum membrane thermoformed poly-4-hydroxybutyrate medical implants

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3731683A (en) * 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4205399A (en) * 1977-06-13 1980-06-03 Ethicon, Inc. Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4849226A (en) * 1981-06-29 1989-07-18 Alza Corporation Method for increasing oxygen supply by administering vasodilator
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
EP0104731B1 (en) * 1982-08-27 1987-11-25 Imperial Chemical Industries Plc 3-hydroxybutyrate polymers
US4856188A (en) * 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
EP0145233B2 (en) * 1983-11-23 1991-11-06 Imperial Chemical Industries Plc Separation processfor a 3-hydroxybutyrate polymer
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
GB8424950D0 (en) * 1984-10-03 1984-11-07 Ici Plc Non-woven fibrous materials
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4648978A (en) * 1985-04-24 1987-03-10 American Sterilizer Company Process for the continuous preparation of sterile, depyrogenated solutions
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
FI75493C (en) * 1985-05-08 1988-07-11 Materials Consultants Oy SJAELVARMERAT ABSORBERBART PURCHASING SYNTHESIS.
AU603076B2 (en) * 1985-12-09 1990-11-08 W.R. Grace & Co.-Conn. Polymeric products and their manufacture
US4664655A (en) * 1986-03-20 1987-05-12 Norman Orentreich High viscosity fluid delivery system
US4758234A (en) * 1986-03-20 1988-07-19 Norman Orentreich High viscosity fluid delivery system
US5032638A (en) * 1986-09-05 1991-07-16 American Cyanamid Company Bioabsorbable coating for a surgical device
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
JPH0725689B2 (en) * 1986-10-07 1995-03-22 中外製薬株式会社 Sustained-release preparation containing granulocyte colony-stimulating factor
NL8603073A (en) * 1986-12-02 1988-07-01 Rijksuniversiteit METHOD FOR PREPARING POLYESTERS BY FERMENTATION; METHOD FOR PREPARING OPTICALLY ACTIVE CARBONIC ACIDS AND ESTERS; POLYESTER INCLUDING PRODUCTS.
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US5059211A (en) * 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US5245023A (en) * 1987-06-29 1993-09-14 Massachusetts Institute Of Technology Method for producing novel polyester biopolymers
US5480794A (en) * 1987-06-29 1996-01-02 Massachusetts Institute Of Technology And Metabolix, Inc. Overproduction and purification of soluble PHA synthase
US5229279A (en) * 1987-06-29 1993-07-20 Massachusetts Institute Of Technology Method for producing novel polyester biopolymers
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US5502158A (en) * 1988-08-08 1996-03-26 Ecopol, Llc Degradable polymer composition
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5085629A (en) * 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
US5026381A (en) * 1989-04-20 1991-06-25 Colla-Tec, Incorporated Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit
US5041100A (en) * 1989-04-28 1991-08-20 Cordis Corporation Catheter and hydrophilic, friction-reducing coating thereon
US5002067A (en) * 1989-08-23 1991-03-26 Medtronic, Inc. Medical electrical lead employing improved penetrating electrode
EP0423484B1 (en) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Tablet with sustained release
JPH0662839B2 (en) * 1989-11-14 1994-08-17 工業技術院長 Microbial degradable plastic molding and method for producing the same
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
IT1247157B (en) * 1991-02-11 1994-12-12 Fidia Spa BIODEGRADABLE AND BIOABSORBABLE GUIDE CHANNELS TO BE USED FOR NERVE REGENERATION.
DE4113984C2 (en) * 1991-04-29 2002-05-08 Koehler Chemie Dr Franz Salts of 4-hydroxy butyric acid
FR2676927B1 (en) * 1991-05-29 1995-06-23 Ibf MICROSPHERES FOR USE IN THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THEM.
US5236431A (en) * 1991-07-22 1993-08-17 Synthes Resorbable fixation device with controlled stiffness for treating bodily material in vivo and introducer therefor
JP2777757B2 (en) * 1991-09-17 1998-07-23 鐘淵化学工業株式会社 Copolymer and method for producing the same
DE69229261T2 (en) * 1991-09-27 1999-11-04 Terumo Corp FLEXIBLE PART FOR MEDICAL USE
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
US5204382A (en) * 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
CH689767A5 (en) * 1992-03-24 1999-10-15 Balzers Hochvakuum Process for Werkstueckbehandlung in a Vakuumatmosphaere and vacuum treatment system.
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5278256A (en) * 1992-09-16 1994-01-11 E. I. Du Pont De Nemours And Company Rapidly degradable poly (hydroxyacid) compositions
GB9223351D0 (en) * 1992-11-06 1992-12-23 Ici Plc Polyesters
GB9223350D0 (en) * 1992-11-06 1992-12-23 Ici Plc Polymer composition
JP3263710B2 (en) * 1992-12-11 2002-03-11 高砂香料工業株式会社 Biodegradable optically active polymer and method for producing the same
US5443458A (en) * 1992-12-22 1995-08-22 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method of manufacture
US5288516A (en) * 1993-02-11 1994-02-22 E. I. Du Pont De Nemours And Company Process of producing bioabsorbable filaments
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5412067A (en) * 1993-05-10 1995-05-02 Mitsui Toatsu Chemicals, Inc. Preparation process of polyester
US5874040A (en) * 1993-06-02 1999-02-23 Monsanto Company Processing of polyesters
GB9311402D0 (en) * 1993-06-02 1993-07-21 Zeneca Ltd Processing of polyesters
JP3243334B2 (en) * 1993-06-10 2002-01-07 テルモ株式会社 Hydroxyalkanoate polymer composition
AU7396294A (en) * 1993-06-25 1995-01-24 Alza Corporation Incorporating poly-n-vinyl amide in a transdermal system
JPH083333A (en) * 1994-06-22 1996-01-09 Tokuyama Corp Melt-extruded film of biodegradable aliphatic polyester and bag comprising the same
AU1560095A (en) * 1994-01-06 1995-08-01 Metabolix, Inc. Methods for synthesizing oligomers containing hydroxy acid units
ZA95627B (en) * 1994-01-28 1995-10-05 Procter & Gamble Biodegradable copolymers and plastic articles comprising biodegradable copolymers
ATE314410T1 (en) * 1994-01-28 2006-01-15 Procter & Gamble BIODEGRADABLE COPOLYMERS AND PLASTIC OBJECTS MADE OF BIODEGRADABLE 3-HYDROXYHEXANOATE COPOLYMERS
DE69531638T2 (en) * 1994-06-06 2004-06-17 Osiris Therapeutics, Inc. BIOMATRIX FOR TISSUE REGENATION
US5629077A (en) * 1994-06-27 1997-05-13 Advanced Cardiovascular Systems, Inc. Biodegradable mesh and film stent
ES2141953T3 (en) * 1994-08-12 2000-04-01 Minnesota Mining & Mfg COMPOSITIONS OF POLY PRESSURE SENSITIVE ADHESIVES (BETA-HIDROXIORGANOATO).
JP3790567B2 (en) * 1994-09-30 2006-06-28 武田薬品工業株式会社 Sustained release agent
US5599852A (en) * 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
US5879322A (en) * 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
DE19539449A1 (en) * 1995-10-24 1997-04-30 Biotronik Mess & Therapieg Process for the production of intraluminal stents from bioresorbable polymer material
JP3369421B2 (en) * 1996-12-18 2003-01-20 理化学研究所 Film composed of poly (3-hydroxybutanoic acid)
EP0973818B1 (en) * 1997-04-03 2004-10-13 Guilford Pharmaceuticals Inc. Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
PT981381E (en) * 1997-05-12 2007-04-30 Metabolix Inc Polyhydroxyalkanoates for in vivo applications
US6610764B1 (en) * 1997-05-12 2003-08-26 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US5876455A (en) * 1997-07-24 1999-03-02 Harwin; Steven F. Bio-shim
EP1042388B1 (en) * 1997-12-22 2006-11-15 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
JPH11199514A (en) * 1998-01-13 1999-07-27 Meiji Seika Kaisha Ltd Sustainably releasing pharmaceutically prepared composition
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US7662409B2 (en) * 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
FR2784580B1 (en) * 1998-10-16 2004-06-25 Biosepra Inc POLYVINYL-ALCOHOL MICROSPHERES AND METHODS OF MAKING THE SAME
CA2363262C (en) * 1999-03-04 2010-09-28 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
WO2000056376A1 (en) * 1999-03-25 2000-09-28 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US6103255A (en) * 1999-04-16 2000-08-15 Rutgers, The State University Porous polymer scaffolds for tissue engineering
WO2001019361A2 (en) * 1999-09-14 2001-03-22 Tepha, Inc. Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
US7025980B1 (en) * 1999-09-14 2006-04-11 Tepha, Inc. Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation
US20020168518A1 (en) * 2001-05-10 2002-11-14 The Procter & Gamble Company Fibers comprising starch and polymers
WO2003066733A1 (en) * 2002-02-05 2003-08-14 Mitsui Chemicals, Inc. Biodegradable resin composition and molded object thereof
US6838492B2 (en) * 2002-06-17 2005-01-04 Scentco, Llc. Scented paints, paint scenting additive mixtures and processes for producing scented paints
PT1778305E (en) * 2004-08-03 2010-07-27 Tepha Inc Non-curling polyhydroxyalkanoate sutures

Also Published As

Publication number Publication date
WO2005007195A1 (en) 2005-01-27
AU2004257701B2 (en) 2007-09-13
ES2395077T3 (en) 2013-02-08
US20050025809A1 (en) 2005-02-03
CA2531833C (en) 2009-10-20
AU2004257701A1 (en) 2005-01-27
EP1651273A1 (en) 2006-05-03
JP2007528853A (en) 2007-10-18
EP1651273B1 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
CA2531833A1 (en) Poly-4-hydroxybutyrate matrices for sustained drug delivery
US20230091533A1 (en) Biodegradable drug delivery compositions
RU2494731C2 (en) Compounds containing clonidine in degradable polymer
ES2641821T3 (en) Solid fast dissolving dosage form
TW487580B (en) Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20140154321A1 (en) Sustained release delivery devices
CA2601304A1 (en) Controlled release formulations of octreotide
WO2005011769A3 (en) Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
WO2005013936A3 (en) Manufacture of long term drug delivery devices with polyurethane based polymers
KR20070083941A (en) Ocular delivery of polymeric delivery formulations
ES2301084T3 (en) IN SITU TRAINING IMPLANT FOR ANIMALS.
Major et al. Implantable drug delivery systems
US20150290170A1 (en) Ketorolac-containing sustained release drug delivery systems
HU206268B (en) Process for producing solid oral forms comprising iphosphamide as active ingredient
US20220233435A1 (en) Controlled release device for oral cavity
Umeyor et al. Pharmaceutical polymers in conventional dosage forms
EP1827377B1 (en) In-situ forming implant for animals
McConville Ian Major1, Sarah Lastakchi2, Maurice Dalton1 and
JP2003113121A (en) Periodontal disease-treating composition

Legal Events

Date Code Title Description
EEER Examination request